YouTubeFacebookLinkedInTwitterinstagramrss

Press Releases

Biodesy Announces Corporate Name Change to BlueLight Therapeutics

SOUTH SAN FRANCISCO, CA, UNITED STATES - May 27, 2020 - Biodesy Inc. today announced that it has changed its corporate name to BlueLight Therapeutics Inc., effective May 20, 2020, and appointed drug discovery expert Mark Gallop, PhD, as Chief Scientific Officer

AI & Medicine — An Expert in AI-aided Drug Discovery and Medical Applications

NEW YORK, NY, UNITED STATES - May 27, 2020 - Recently founded, the New York-based company AI & Medicine is an expert in the field of AI-Powered drug discovery, personalized healthcare and various medical applications

Alfa Chemistry Offers PEG linkers for the Science Community in Bioconjugation and Pegylation

NEW YORK, NY, UNITED STATES - May 27, 2020 - Earlier this month in May, 2020, the world's leading chemical supplier Alfa Chemistry announced that a total of close to 800 PEG linker products are now available for its customers worldwide, including acid PEG linkers, alkyl PEG linkers, amino PEG linkers, azido PEG linkers, benzyl PEG linkers, biotin PEG linkers, fmoc PEG linkers, NHBoc PEG linkers, NHS ester PEG linkers, t-butyl ester PEG linkers, THP PEG linkers, and other PEG Linkers

2bPrecise Solution Wins 2020 MedTech Breakthrough Award

PITTSBURGH, PA, UNITED STATES - May 26, 2020 - 2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, has been recognized as the “Best Overall Genomics Solution” in the fourth annual MedTech Breakthrough Awards program

ALBUMEDIX ANNOUNCE JONAS SKJØDT MØLLER AS NEW CHIEF EXECUTIVE OFFICER

NOTTINGHAM, ENGLAND - May 26, 2020 - Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today its succession plan as Peter Rosholm, after 13 years leading the company, has decided to step down as CEO and handover the company’s leadership

Successful partnership between MolPort and BioAscent reaches 100-project milestone

BEACON, NY - May 26, 2020 - Successful partnership between MolPort and BioAscent reaches 100-project milestonePartnership enhances customer service and simplifies logistics of compound sourcing for scientists MolPort Inc

EchelonDx Launches Mobile COVID-19 Testing and Vaccination Verification Application to Help Reopen Local Businesses, Restore Employment and Revive Economic Growth

RENO, NV, UNITED STATES - May 26, 2020 - Echelon Diagnostics, Inc., a leading provider of genomic healthcare AI imaging and big data solutions, today announced the commercial launch of the SafeKey™ Health Passport (Patent Pending)

Rho to Coordinate Study Sponsored by National Institute of Allergy and Infectious Diseases to Determine Rate of COVID-19 Infection in US Children

DURHAM, NC, US - May 21, 2020 - For Immediate Release Rho to Coordinate Study Sponsored by National Institute of Allergy and Infectious Diseases to Determine Rate of COVID-19 Infection in US ChildrenNIH-funded study also aims to identify percentage of children infected with the new coronavirus that develop symptoms of the disease Research Triangle Park, NC - May 21, 2020 - Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced it is coordinating a new study, called Human Epidemiology and Response to SARS-CoV-2 (HEROS), to help determine the rate of the new coronavirus infection in children and their family members in the U

Microway Supports AI Leaders, Delivers First NVIDIA DGX A100 to a US Educational Institution

PLYMOUTH, MA, UNITED STATES - May 20, 2020 - Microway, a leading provider of advanced hardware for AI and HPC, announces it is delivering the first NVIDIA DGX A100 system to a higher education institution in the United States

DermTech PLA Included in Peer Review Article of Novel Molecular Technologies for Melanoma Management with Potential to Address Current Gaps in Diagnostic Accuracy and Prognostication

LA JOLLA, CA - May 20, 2020 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that the DermTech Pigmented Lesion Assay (the “DermTech PLA”) is reviewed in the Journal of the American Academy of Dermatology (“JAAD”) by leading dermatologists at the New York University School of Medicine as one of four novel molecular technologies with the potential to address current gaps in melanoma management through improved diagnostic accuracy and prognostication

2bPrecise honored as recipient of the 2020 Microsoft Health Innovation Awards

PITTSBURGH, PA, UNITED STATES - May 20, 2020 - 2bPrecise™ Precision Health™ platform has been named a recipient of Microsoft Corp.’s 2020 Health Innovation Awards, in the category of “Reimagine Healthcare

Sterling Pharma Solutions commence the production of potential COVID-19 treatment

DUDLEY, UNITED KINGDOM - May 11, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19

ArisGlobal Introduces LifeSphere CTMS10, Bringing Modern Simplicity and Efficiency to Clinical Trial Management

MIAMI, FL - May 4, 2020 - MIAMI, FL April 21, 2020 - ArisGlobal, the leading provider of software that automates core drug development functions for over 300 life sciences companies, today announced the release of LifeSphere CTMS10, a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizes

Two Top 25 Global Pharma Companies Adopt LifeSphere® Intake and Triage to Automate Adverse Event Case Processing

MIAMI, FL, UNITED STATES - May 1, 2020 - MIAMI, FL April 20, 2020 - ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 300 life sciences companies, today announced that two large multi-national pharmaceutical companies have selected the LifeSphere® Intake and Triage solution to bring substantial efficiency gains to adverse event case processing across their global affiliates

The Pistoia Alliance Launches Toolkit to Accelerate Implementation of FAIR Data Principles

BOSTON, MA - May 14, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today launched a freely accessible toolkit to help companies implement the FAIR (Findable, Accessible, Interoperable, Reusable) guiding principles for data management and stewardship

Kyruus to Power Boston Children’s Hospital’s Next Phase of Digital Transformation

BOSTON, MA, UNITED STATES - May 13, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Boston Children’s Hospital, the top pediatric hospital in the United States, has engaged the company to enhance access to its world-renowned providers and facilities

Engility® CTMS Selected by Leading US Health Outcomes and Technology Company for its Clinical Trial Programmes

, ENGLAND - May 12, 2020 - PHARMASEAL, a new provider of clinical trial management and governance solutions, announced today that a leading US health outcomes and technology company has selected Engility® Clinical Trial Management system for the management and oversight of its clinical trial programmes

SEKISUI XenoTech Receives New US Patent for a Method to Evaluate Xenobiotics as Immune-Modulators of Drug Transport and Metabolism in Hepatocytes

KANSAS CITY, KS, UNITED STATES - May 12, 2020 - SEKISUI XenoTech has been awarded US patent # 10,648,968 “In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes

Proof-of-Concept Research Demonstrates Patients Reliably Perform Remote Self-Sampling of Concerning Moles Using DermTech’s Non-Invasive Adhesive Skin Collection Kit Under Physician Supervision via Tel

LA JOLLA, CA, US - May 11, 2020 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that SKIN, the official journal of the National Society for Cutaneous Medicine, published proof-of-concept data demonstrating that patients are able to reliably perform remote self-sampling of concerning moles using the DermTech Pigmented Lesion Assay (the “DermTech PLA”) under physician supervision via telemedicine, enabling actionable molecular testing for accurate melanoma detection

The Melanoma Research Foundation Hosting Weekly Facebook Live ‘Ask a Dermatologist’ Sessions throughout Melanoma Awareness Month

LA JOLLA, CA, US - May 5, 2020 - DermTech, Inc. (NASDAQ: DMTK) (“DermTech”) and the Melanoma Research Foundation (MRF) recognize Melanoma Awareness Month this May with an “Ask a Dermatologist” webinar series offered on MRF’s Facebook page every Thursday throughout the month to raise awareness of melanoma and educate around the dangers of the fastest growing and most deadly form of skin cancer
 1